Jasper Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Jasper Therapeutics Operating Expenses Growth & History (JSPR)
Jasper Therapeutics's operating expenses was $83.9M for fiscal 2025.
View full Jasper Therapeutics company overviewJasper Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $83.9M | $7.6M | +10.03% |
| 2024 | 2024-12-31 | $76.2M | $7.4M | +10.71% |
| 2023 | 2023-12-31 | $68.9M | $17.7M | +34.50% |
| 2022 | 2022-12-31 | $51.2M | $14.4M | +38.99% |
| 2021 | 2021-12-31 | $36.8M | $16.1M | +78.08% |
| 2020 | 2020-12-31 | $20.7M | — | — |
Jasper Therapeutics quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.2M | −$17.9M | −66.00% |
| Q1 2026 | 2026-03-31 | $11.0M | −$10.8M | −49.77% |
| Q4 2025 | 2025-12-31 | $15.8M | −$9.4M | −37.36% |
| Q3 2025 | 2025-09-30 | $19.2M | −$723,000 | −3.64% |
| Q2 2025 | 2025-06-30 | $27.1M | $11.1M | +69.30% |
| Q1 2025 | 2025-03-31 | $21.8M | $6.7M | +44.65% |
| Q4 2024 | 2024-12-31 | $25.3M | $7.6M | +42.65% |
| Q3 2024 | 2024-09-30 | $19.9M | $527,000 | +2.72% |
| Q2 2024 | 2024-06-30 | $16.0M | −$1.8M | −10.29% |
| Q1 2024 | 2024-03-31 | $15.1M | $1.1M | +8.07% |
| Q4 2023 | 2023-12-31 | $17.7M | $4.0M | +28.94% |
| Q3 2023 | 2023-09-30 | $19.4M | $6.7M | +52.36% |
| Q2 2023 | 2023-06-30 | $17.8M | $5.9M | +49.02% |
| Q1 2023 | 2023-03-31 | $13.9M | $1.2M | +9.15% |
| Q4 2022 | 2022-12-31 | $13.7M | — | — |
| Q3 2022 | 2022-09-30 | $12.7M | $2.6M | +26.08% |
| Q2 2022 | 2022-06-30 | $12.0M | $3.5M | +42.11% |
| Q1 2022 | 2022-03-31 | $12.8M | $6.5M | +104.32% |
| Q3 2021 · Sep 30 | 2021-09-30 | $10.1M | $4.1M | +67.76% |
| Q2 2021 | 2021-06-30 | $8.4M | — | — |
| Q1 2021 | 2021-03-31 | $6.3M | — | — |
| Q3 2020 | 2020-09-30 | $6.0M | — | — |
Jasper Therapeutics operating expenses trends
Over the last five fiscal years, Jasper Therapeutics's operating expenses increased from $20.7M to $83.9M, a change of $63.2M. The latest reported quarter, Q2 2026, shows $9.2M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jasper Therapeutics source filings ↗